Golden
Pontifax Venture Capital

Pontifax Venture Capital

Israeli venture capital firm funding Israeli bio-pharmaceutical and life science companies.

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Funding

Pontifax Venture Capital funds companies at various stages of development, from early stage to growth capital. It specializes in funding companies that are based in Israel. The firm prefers to fund companies operating in the pharmaceutical and life science industry sectors. Since January 2016, the firm has managed to raise $585 million through three funding rounds. Its most recent funding round was held in November 2018, amassing $170 million.

Timeline

Associated investment funds

3 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Location
Location
Date signed
Date signed

Funded Companies

9 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.

LogicBio Therapeutics is a Cambridge, Massachusetts-based company.

Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug.

Prevail Therapeutics is a New York City-based company.

89Bio is a San Francisco-based biopharmaceutical company.

People

Name
Role
LinkedIn

Ohad Hammer

Partner



Ran Nussbaum

Managing Partner/Partner/Founder



Tomer Kariv

Chief Executive Officer/Founder



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

89bio







ABAC Therapeutics







Dynacure







Horama







Keros Therapeutics







Step Pharma







References